Delhi High Court grants interim; restrains sale of Corex syrup
Sale of over 300 drugs' combination have been banned; HC granted relief saying they've been in business for 25 years
The Delhi High Court today granted interim stay of notification restraining sale of pharma major Pfizer's cough syrup 'Corex' and directed the government not to take coercive steps against the company.
Justice Rajiv Sahai Endlaw granted the interim relief to the company saying it has been selling the cough syrup for the last 25 years.
Read more from our special coverage on "PFIZER"
The court also issued notice to the Health ministry directing it to file status report after taking instruction on what was the finding of the expert committee set up by it following which sale of over 300 drugs' combination have been banned across India with effect from March 10.
"List on Monday. Till then the effect of notification by the petitioner shall remain stayed. No coercive steps till then," the court said.
The court's order came on a plea moved by Pfizer who contended that no show cause notice or hearing was granted prior to the notification.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
First Published: Mon, March 14 2016. 18:11 IST